Personalized healthcare
Roche is a pioneer in personalized healthcare
The best treatments in the world are most effective only when we link them to the right patients, at the right time. For over two decades, Roche has been at the forefront of personalized healthcare, working to support the medical field as it moves toward patient-centricity. We know that PHC is at the heart of your therapeutic strategy, and why assay customization is of critical importance.
PHC is central to Roche’s approach and has played a key role in our advancements in precision medicine throughout the patient journey, from early detection and diagnosis to treatment eligibility. Partner with us as we leverage new opportunities in IHC/ISH and multiplexing, digital pathology, immunochemistry, PCR and NGS to improve decision-making and deliver value-based, outcome-driven healthcare across disease areas.
PATIENT STORIES
Lung cancer patient going for the cure
The Nerstads find joy in making a difference for other cancer warriors, and in the sweet moments wrapped tightly in the love of family.
PATIENT STORIES
Elevating hope through breast cancer innovation
A breakthrough in diagnostic testing is helping to improve outcomes for patients like Enisa Besic, who is receiving new targeted treatment to combat what’s known as HER2-low breast cancer.
We see an enormous potential and huge opportunities in PHC. Targeted therapies and diagnostic tests that help to improve medical decision making not only offer clinical benefits for patients but are also attractive through health economic benefits to regulatory authorities and payers.
Severin Schwan
Chairman of the Board, Roche
Explore how Roche is advancing precision medicine
Diagnostics for smarter decisions
Companion diagnostics are only the beginning in our quest to enable the best therapy decision for every patient.
Data-driven medicine
New technologies are providing insights that are altering the course of healthcare to help patients live longer, healthier lives.
Collaboration is key
Roche is collaborating with global health and technology leaders, governments, clinicians and advocates to help fulfill the promise of personalized medicine.